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Introduction: We present the case of a patient with non-infectious osteomyelitis of the mandible, which is a
recognized but unusual condition of unknown cause.
Case presentation: A 14-year-old Caucasian girl presented with pain and edema in the left side of her jaw. A
clinical examination led to a diagnosis of osteomyelitis and she was treated with antibiotics. Our patient continued
antibiotic treatment for osteomyelitis and underwent decortication. Histology based on a biopsy showed new bone
formation and chronic inflammation, and a diagnosis of sclerotic osteomyelitis was made. Over the next few years,
she experienced pain on the left side of her jaw and increasing edema, and the size of the left side of her jaw bone
increased. She was then sent to our Department of Medicine at the age of 16 years. Her symptoms included pain
in the left side of her jaw that scored 4 on a visual analogue scale of 1 to 10. A diagnosis of bone disease was made
based on bone scintigraphy and single photon emission computed tomography that showed hot spots in the
affected left side of the jaw. Our patient was treated with a single dose of intravenous zoledronic acid (5mg) at age
17 years, which was repeated after 12 months. The bone pain was significantly reduced six months after treatment
and had disappeared 24 months after treatment.
Conclusion: We report an unusual localization of non-infectious osteomyelitis of the jaw in a young woman. Even
though the presentation was in the jaw, her condition improved after intravenous bisphosphonate treatment, as
evaluated by reduced clinical symptoms, bone turnover evaluation as assessed by biochemical bone markers, and
reduced activity on bone scintigraphy.
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Subacute and chronic symmetrical osteomyelitis was first
described by Giedion et al. [1]. In this report, the disorder
involved the metaphyses of long bones either simultan-
eously or successively. Later publications reported the in-
volvement of additional bone sites and used the terms
chronic multifocal osteomyelitis and chronic recurrent
multifocal osteomyelitis (CRMO) [2,3]. The disease is rare,
accounting for 2% to 5% of all osteomyelitis cases. It pri-
marily affects children, with a female to male ratio of 5:1,
with no racial predilection [4]. In a five-year follow-up
study of 23 patients published in 2002, the median age of* Correspondence: peter.schwarz@regionh.dk
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distribution, and reproduction in any mediumonset was 10 years with a reported range of 4 to 14 years
[4]. Chun reported on a female patient who did not have
any prior dental infection or skin manifestations associ-
ated with CRMO. That patient was treated with oral pred-
nisone and alendronate, and naproxen (Naprosyn) as
needed for pain [5]. However, after six and a half years of
treatment, the patient had persistent facial deformity due
to diffuse bilateral mandible enlargement. In this case and
review by Chun, it was concluded that clinicians caring for
children should be familiar with CRMO because it typic-
ally occurs during childhood and should be included in
the differential diagnosis of patients presenting with signs
and symptoms of unifocal osteomyelitis. Because other
sites of bone involvement may be asymptomatic, a bone
scan is recommended for patients with negative bacterial
cultures from bone biopsies and for those presenting with
mandibular inflammation.tral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited.
Figure 1 Bone scintigraphy of the patient at month 0.
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myelitis in the mandible of a young woman.
Case presentation
A 14-year-old Caucasian girl presented to her local dentist
with pain and edema in the left side of her jaw, with a
maximum mouth opening of 31mm. Histology and a clin-
ical examination resulted in a diagnosis of osteomyelitis
and she was treated with antibiotics. She then underwent
surgical decortication at a hospital department of dental
surgery. Histology based on a biopsy showed new bone
formation and chronic inflammation, and she was diag-
nosed with sclerotic osteomyelitis. There was no clinical
improvement after the decortication, and over the next
few years she experienced pain in the left side of her jaw
and increasing edema, and the size of the left side of her
jaw bone increased.
Our patient was admitted to our Department of Medicine
at the age of 16 years. Her symptoms included pain in the
left side of her jaw that scored a 4 on a visual analogue
scale of 1 to 10. There was a visible difference in the two
halves of our patient’s face, with increased soft tissue and
edema on her left side. She had menarche at 13 years of
age and regular menses. There was no change of pain
during her menstrual cycle. Our patient had normal
plasma C-reactive protein (<10mg/L), plasma calcium ion
(1.23mmol/L) and plasma parathyroid hormone (1–84)
(29ng/L), but low plasma 25-hydroxyvitamin D (vitamin
D; 23nmol/L; reference range >50nmol/L) and high
plasma alkaline phosphatase (122U/L; reference range 35
to 105U/L). Her weight was 58.3kg, height 168.6cm and
body mass index 20kg/m2. Her bone mineral density was
measured and found to be normal (T-score of spine +0.1
and hip −0.3).
A diagnosis of bone disease was made based on bone
scintigraphy (Figure 1), single photon emission computed
tomography (SPECT) (Figure 2) showing hot spots in the
affected side of the jaw, and the above biochemistry. This
led to a re-analysis of the bone biopsy by two specialists.
The biopsy did not allow an assessment of any increased
activity by osteoclasts and osteoblasts. Bone remodeling
was disorganized, with persistence of woven bone and most
likely diagnostic of non-infectious osteomyelitis.
Our patient was initially treated with vitamin D until the
deficit had corrected. This had no effect on the disease.
Thereafter, at age 17, she was treated with a single 5mg
dose of intravenous zoledronic acid (Aclasta) that was re-
peated after 12 months. After 24 months of treatment, the
left-side soft tissue and facial edema of our patient
remained unchanged. However, her bone pain was signifi-
cantly reduced six months after the first zoledronic acid
treatment and had disappeared 24 months after treatment.
The maximal opening of her mouth was unchanged after
six months of treatment, but had increased from 31mm to63mm after 24 months of treatment. Biochemistry at
24 months showed normalized plasma alkaline phos-
phatase (73U/L; reference range 35 to 105U/L) and
unchanged C-reactive protein (<10mg/L; within the
reference range). SPECT at 24 months of treatment
showed less activity in the affected hot spot on the left
side of her jaw (right-left ratio 1:16.4 at baseline and
1:4.4 after 24 months of treatment, Figure 2). Control
markers of bone turnover were suppressed: plasma
CTX, 0.04μg/L (reference range: 0.11 to 0.74μg/L) and
plasma osteocalcin, 2.4μg/L (reference range: 10.4 to
Figure 2 Single photon emission computed tomography of the jaw at month 0 before treatment, panel A (left-right ratio 1:16.4)
and after 24 months of zoledronic acid treatment, panel B (left-right ratio 1:4.4).
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mal range at 11.6μg/L (reference range: 4.7 to 27.0μg/L).
Discussion
CRMO is a relapsing inflammatory disease affecting a
variety of bones such as the mandible, spine, pelvis, ster-
num and scapula in addition to the originally described
long bones [3]. The reported cases are all multifocal and
only few adult cases has been reported [5].
We have presented a case of unifocal bone disease in
the mandible. The histological report of woven bone was
non-specific as were the abnormalities on isotope scan
and SPECT. However, these findings could be caused by
non-infectious osteomyelitis of the mandible, which is a
recognized but unusual condition of unknown cause.
The biopsy in our case confirmed our diagnosis of
osteomyelitis. Furthermore, osteomyelitis was suspected in
our patient at age 14. She was treated by relevant antibi-
otics for several months but with no clinical response.
Evaluations by SPECT, bone scintigraphy and biochemis-
try provided no definitive diagnosis. A diagnosis of non-
infectious osteomyelitis was assumed but could not be
confirmed. Our case has several similarities to the review
and case presented by Chun, even though our patient’s
disease had, throughout the years, only presented as a uni-
focal non-infectious osteomyelitis [5].
The differential diagnosis for our patient had included
Paget’s disease of the bone (PDB) [6]. However, the age
of our patient and the biopsy evaluation were against
this diagnosis, despite one of three specialists suggestinga diagnosis of PDB. Early-onset familial PDB would be
an outside possibility, but with no family history it
seemed unlikely. Another possible explanation could
have been fibrous dysplasia or other anomaly of bone
structure.
We decided to treat our patient’s bone abnormality with
bisphosphonate and chose zoledronic acid. Another op-
tion could have been pamidronate, a less potent bisphos-
phonate. Even though our patient was young, we chose
the most potent bisphosphonate as it was assumed that
she might only be treated once and, in cases of PDB, it has
been observed that a single treatment with zoledronic acid
can reduce bone activity for several years. Our case dem-
onstrates that zoledronic acid rapidly decreases bone activ-
ity as evaluated by biochemistry and by bone SPECT. The
clinical improvement in pain was significant at month six
of treatment. The treatment also led to increased mouth
opening, which more than doubled from 31mm to 63mm
by month 24 of treatment, thereby significantly improving
quality of life for our young female patient.Conclusion
We have described an unusual localization of non-
infectious osteomyelitis of the jaw in a young woman. Even
though the presentation was in her jaw, the bone condition
improved after intravenous bisphosphonate treatment, as
evaluated by reduced clinical symptoms, bone turnover
evaluation assessed by biochemical bone markers, and re-
duced activity on bone scintigraphy.
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